Zhang Bao-gui, Du Tao, Zang Ming-de, Chang Qing, Fan Zhi-yuan, Li Jian-fang, Yu Bei-qin, Su Li-ping, Li Chen, Yan Chao, Gu Qin-long, Zhu Zheng-gang, Yan Min, Liu Bingya
Shanghai Key Laboratory of Gastric Neoplasms, Department of Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Gastric Neoplasms, Department of Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Department of Surgery, Shanghai East Hospital, Tongji University School of Medicine, No 150 Jimo Road, Shanghai, China.
Oncotarget. 2014 Nov 15;5(21):10584-95. doi: 10.18632/oncotarget.2513.
Androgen receptor (AR) plays an important role in many kinds of cancers. However, the molecular mechanisms of AR in gastric cancer (GC) are poorly characterized. Here, we investigated the role of AR in GC cell migration, invasion and metastatic potential. Our data showed that AR expression was positively correlated with lymph node metastasis and late TNM stages. These findings were accompanied by activation of AKT and upregulation of matrix metalloproteinase 9 (MMP9). AR overexpression induced increases in GC cell migration, invasion and proliferation in vitro and in vivo. These effects were attenuated by inhibition of AKT, AR and MMP9. AR overexpression upregulated MMP9 protein levels, whereas this effect was counteracted by AR siRNA. Inhibition of AKT by siRNA or an inhibitor (MK-2206 2HC) decreased AR protein expression in both stably transfected and parental SGC-7901 cells. Luciferase reporter and chromatin immunoprecipitation assays demonstrated that AR bound to the AR-binding sites of the MMP9 promoter. In summary, AR overexpression induced by AKT phosphorylation upregulated MMP9 by binding to its promoter region to promote gastric carcinogenesis. The AKT/AR/MMP9 pathway plays an important role in GC metastasis and may be a novel therapeutic target for GC treatment.
雄激素受体(AR)在多种癌症中发挥重要作用。然而,AR在胃癌(GC)中的分子机制尚不清楚。在此,我们研究了AR在GC细胞迁移、侵袭和转移潜能中的作用。我们的数据表明,AR表达与淋巴结转移和晚期TNM分期呈正相关。这些发现伴随着AKT的激活和基质金属蛋白酶9(MMP9)的上调。AR过表达在体外和体内均诱导GC细胞迁移、侵袭和增殖增加。抑制AKT、AR和MMP9可减弱这些作用。AR过表达上调MMP9蛋白水平,而AR siRNA可抵消这种作用。siRNA或抑制剂(MK-2206 2HC)抑制AKT可降低稳定转染和亲本SGC-7901细胞中的AR蛋白表达。荧光素酶报告基因和染色质免疫沉淀试验表明,AR与MMP9启动子的AR结合位点结合。总之,AKT磷酸化诱导的AR过表达通过与其启动子区域结合上调MMP9,从而促进胃癌发生。AKT/AR/MMP9通路在GC转移中起重要作用,可能是GC治疗的新靶点。